IL22 and chronic obstructive pulmonary disease: To explore the role of IL-22 in the COPD mouse model and the protective effects of AG490 and fezakinumab on emphysema, we evaluated the expression of IL-22R1 in mouse lung tissue using immunohistochemistry (Figure 4(a)).